Cardiac valvular disease in scleroderma and systemic lupus erythematosus/scleroderma overlap associated with antiphospholipid antibodies

Journal of Rheumatology

Volumn 23, Issue 12, 1996, Pages 2171-2174

  Penmetcha, Mohan ^a,b   Rosenbush, Stuart W ^a,c   Harris, Charlotte A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Division of Rheumatology   (United States)

^c Division of Cardiology   (United States)

Author keywords

antiphospholipid antibody syndrome; cardiac valvular disease; scleroderma

Indexed keywords

AZATHIOPRINE; PENICILLAMINE; PREDNISONE; VERAPAMIL; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; VALVULAR HEART DISEASE;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ECHOCARDIOGRAPHY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MITRAL VALVE INSUFFICIENCY; SCLERODERMA, LOCALIZED;

EID: 0030471576     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Harris EN, Pierangeli SS: Antiphospholipid antibodies and the antiphospholipid syndrome. Springer Semin Immunopathol 1994;16:223-45.
2. Anderson D, Bell D, Lodge R, Grant E: Recurrent cerebral ischemia and mitral valve vegetation in a patient with antiphospholipid antibodies. J Rheumatol 1987;14:839-41.
3. Galve E, Ordi J, Barquinero J. Evangelista: Valvular heart disease in the primary antiphospholipid syndrome. Ann Intern Med 1992;116:293-8.
4. Asherson RA, Khamashta MA, Ordi-Ros J, et al: The "primary" antiphospholipid syndrome: Major clinical and serological features. Medicine (Baltimore) 1989;68:366-74.
5. Asherson RA, Lubbe WE: Cerebral and valve lesions in SLE: Association with antiphospholipid antibodies. J Rheumatol 1988;15:539-43.
6. Khamashta MA, Cervera R, Asherson RA, et al: Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990;335:1541-4.
7. Keane A, Woods R, Dowding V, Roden D, Barry C: Anticardiolipin antibodies in rheumatoid arthritis. Br J Rheumatol 1987;26:346-50.
8. Buchanan RRC, Wardlaw JR, Riglar AG, Littlejohn GO, Miller MH: Antiphospholipid antibodies in the connective tissue diseases: Their relation to the antiphospholipid syndrome and Forme Fruste disease. J Rheumatol 1989;16:757-61.
9. Ingram SB, Goodnight SH, Bennett RM: An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: Report of two cases. Arthritis Rheum 1987;30:1167-72.
10. Shapiro LS: Large vessel arterial thrombosis in systemic sclerosis associated with antiphospholipid antibodies. J Rheumatol 1990;17:685-8.
11. Whittaker R, Barnett A, Ryan P: Antiphospholipid syndrome in scleroderma. J Rheumatol 1993;20:1598-600.
12. Siebold JR: Connective tissue diseases characterized by fibrosis: Scleroderma. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of Rheumatology, 4th ed. Philadelphia: WB Saunders, 1993:1113-43.
13. Katayama I, Otoyama K, Kondo S, Nishioka K, Nishioka S: Clinical manifestations in anticardiolipin antibody-positive patients with progressive systemic sclerosis. J Am Acad Dermatol 1990;23:198-201.
14. Ford SE, Charrette EJP, Knight J, Pym J, Ford P: A possible role for antiphospholipid antibodies in acquired cardiac valve deformity. J Rheumatol 1990;17:1499-503.